Hypoactive Sexual Desire in Men

Standard Practice in Sexual Medicine

Volumn , Issue , 2008, Pages 149-157

  Rubio Aurioles, Eusebio ^a  

^a Fundacion Mexicana para la Salud AC   (Mexico)

Author keywords

Clustering; Ejaculation; Medical disorder; Sexual desire; Sexual dysfunctions

Indexed keywords

EID: 84889361910     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470755235.ch13     Document Type: Chapter

References (46)

1. Pridal CG, Lopiccolo J. Multi element treatment of desire disorders: integration of cognitive, behavioral, and sytemic therapy In: Leiblum SR, Rosen RC, eds. Principles and Practice of Sex Therapy, 3rd edn. New York:The Guilford Press, 2000.
2. Meuleman EJ, Van Lankvled J. Hypoactive sexual desire disorder: an underestimated condition in men. BJU Int 2005;95:201-296.
3. Lief HI. Hypoactive sexual desire. Medical Aspects of Human Sexuality 1977;7:94-95.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. Washington DC:American Psychiatric Association, 1980.
5. Corona G, Mannucci E, Petrone L, Giommi R, Mansani R, Fei L, Forti G, Maggi M. Psycho-biological correlates of hypoactive sexual desire in patients with erectile dysfunction. Int J Impot Res 2004;16:275-281.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn.Washington, DC:American Psychiatric Association, 2000.
7. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999;281(6):537-544.
8. Clogg CC. Latent class models. In: Arminger G, Clogg CC, Sobel ME, eds. Handbook of Statistical Modeling for the Social and Behavioral Sciences. New York, NY: Plenum Press, 1995 pp. 311-359.
9. McCutcheon AL. Latent Class Analysis. Newbury Park, Calif: Sage Publications, 1987.
10. Laumann EO, Nicolosi A, Glasser DB, Paik A, Ginge C, Moreira E, Wang T. Sexual problems among women and men aged 40-80 yrs: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Imp Res 2005;17:39-57.
11. Levine SB. The nature of sexual desire: a clinician's perspective. Arch Sex Behav 2003 Jun;32(3):279-285.
12. Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000;57:1012-1030.
13. Davidson JM, Kwan M, Greenleaf WJ. Hormonal replacement and sexuality. Clin Endocrinol Metab 1982;11:599-623.
14. Kwan M, Greenleaf WJ, Mann J, Crapo L, Davidson JM. The nature of androgen action on male sexuality: a combined laboratory/self-report study on hypogonadal men. Clin Endocrinol Metab 1983;57:557-562.
15. Skakkeoaek NE, Bancroft J, Davidson DW, Warner P. Androgen replacement with oral testosterone undecanoate in hypogonodal men: a double-blind controlled study. Clin Endocrinol 1981;14:49-61.
16. Halpern CT, Udry JR, Campbell B, Suchindran C, Mason GA. Testosterone and religiosity as predictors of sexual attitudes and activity among adolescent males: a biosocial model. J Biosoc Sci 1994;26:217-234.
17. Udry JR, Billy JO, Morris NM, Groff TR, Raj MH. Serum androgenic hormones motivate sexual behavior in adolescent boys. Fertil Steril 1985;43:90-94.
18. Schiavi RC, White D. Androgen and male sexual function:A review of human studies. J Sex Marital Ther 1976;2:214-228.
19. Bancroft J, Tennent G, Loucas K, Cass J. The control of deviant sexual behavior by drugs. I: Behavioral changes following oestrogens and anti-androgens. Br J Psychiatry 1974;125:310-315.
20. Heller CG, Laidlaw WM, Harvey HT, Nelson WO. Effects of progestational compounds on the reproductive processes of the human male. Ann N Y Acad Sci 1958;71:649-665.
21. Money J. Use of an androgen-depleting hormone in the treatment of male sex offenders. J Sex Res 1970;6:165-172.
22. Bancroft J. Hormones and human sexual behavior. J Sex Martial Ther 1984;10:3-21.
23. Bancroft J, O'Carroll R, McNeilly A, Shaw R. The effects of bromocriptine on the sexual behavior of a hyperprolactinaemic man: a controlled case study. Br J Psychiatry 1984;21:131-137.
24. Buckman MT, Kellner R. Reduction of distress in hyperprolactinemia with bromocriptine. Am J Psychiatry 1984;6:351-358.
25. Dornan WA, Malsbury CW. Neuropeptides and male sexual behavior. Neurosci Biobehav Rev 1989;13:1-15.
26. Muller P, Musch K, Wolf AS. Prolactin: variables of personality and sexual behavior. In: Zichella L, Pancheri P, eds. Psychoneuroendocrinology in Reproduction. Amsterdam, the Netherlands: Elsevier/North Holland Biomedical Press, 1979, pp. 357-372.
27. Starkman MN, Schteingart DE, Schork MA. Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels. Psychosom Med 1981;43:3-18.
28. Cutler WB, Friedmann E, McCoy NL. Pheromonal influences on sociosexual behavior in men. Arch Sex Behav 1998;27:1-13.
29. Montejo-Gonzalez AL, Llorca G, Izquierdo JA, Ledesma A, Buosono M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, De La Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E. SSRI-Induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997;23:176-193.
30. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989;12:375-383.
31. White JM, Rumbold GR. Behavioral effects of histamine and its antagonists: a review. Psychopharmacology 1988;95:1-14.
32. Morales A, Buvat J, Gooren LJ, Guay AT, Kaufman JM, Kim YC, Tan HM, Torrres LO. Endocrine Aspects of Men Sexual Dysfunction. In: Lue TF, Basson R, Rosen R, Guiliano F, Khoury S, Montorsi F, eds. Sexual Medicine:Sexual Dysfunction in Men and Wome: 2nd International Consultation on Sexual Dysfunctions. Paris: Health Publications, 2004.
33. Dei M, Verni A, Bigozzi L, Bruni V. Sex steroids and libido. European Journal of Contraception & Reproductive Health Care 1997 Dec;2(4):253-258.
34. Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, Jannini EA. Multicenter study on the prevalence of sexual symptoms in male hypo-and hyperthyroid patients. J Clin Endocrinol Metab 2005;90:6472-6479.
35. Kaplan HS. The sexual desire disorders: dysfunctional regulation of sexual motivation. New York: Brunner/Mazel, 1995.
36. LoPiccolo J, Friedman J. Broad spectrum treatment of low sexual desire: integration of cognitive, behavioral and systemic therapy. In: Lieblum S, Rosen R, eds. Sexual Desire Disorders. New York: The Guilford Press, 1988.
37. Schiavi RC. Interview, psychometric and psycho physiologic strategies to assess sexual disorders. J Clin Psychiatr Monogr 1992;10, No. 19.
38. Hoyl MT, Alessi CA, Harker JO, et al. Development and testing of a five-items version of the Geriatric Depression Scale. J Am Geriatr Soc 1999;47:873-878.
39. Rinaldi P, Mecocci P, Benedetti C, Ercolani S, Bregnocchi M, Menculini G, Catani M, Senin U, Cherubini A. Validation of the five-item geriatric depression scale in elderly subjects in three different settings J Am Geriatr Soc 2003 May;51(5):694-698.
40. Begin C, Sabourin M, Bovin E. Frénetté. Paradis. The Couple-Part 1-Couple distress factors associated with evaluating the spousal relationship. In: Quebec Longitudinal Study of Child Development (QLSCD 1998-2002) From Birth to 29 Months. Québec: Institut de la statistique du Québec, Vol 2 No. 11.
41. Ferris RM, Cooper BR, Maxwell RA. Studies of bupropion's mechanism of antidepressant activity. J Clin Psychiact 1983;44:74-78.
42. Segraves RT, Croft H, Kavoussi R, Ascher JA, Batey SR, Foster VJ, Bolden-Watson C, Metz A. Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women. J Sex Marital Ther 2001 May-Jun;27(3):303-316.
43. Segraves RT, Clayton A, Croft H, Wolf A, Warnock J. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 2004 Jun;24(3):339-342.
44. Crenshaw TL, Goldberg JP, Stern WC. Pharmacologic modification of psychosexual dysfunction. J Sex Marital Ther 1987;13(4):239-252.
45. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N, and the testosterone gel study group. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 2000;85:839-853.
46. Rosen RC. Psychogenic erectile dysfunction. Classification and management. Urol Clin North Am 2001 May;28(2):269-278.